CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The objective of the study is to compare the efficacy and safety of 3 doses CS02 Tablet in combination with a stable dose of metformin monotherapy against CS02 PTM (placebo) Tablet in combination with a stable dose of metformin monotherapy over a 12 weeks treatment period in subjects with type 2 diabetes mellitus with inadequate glycemic control on metformin alone.
Epistemonikos ID: d2d55dfbfec4ccefe3014ad87ee6e4af365d99ee
First added on: May 21, 2024